Patient 2 was a 31-year old male (MB_2) diagnosed with medulloblastoma, SHH-activated and TP53-wildtype (WHO grade IV), and presenting with an unusual relapse involving the nuchal lymph nodes but not the primary site. Here, TP53 is linked to medulloblastoma.